TherapeuticsMD (TXMD) Misses Q2 EPS by 12c

TherapeuticsMD (NASDAQ: TXMD) reported Q2 EPS of ($0.09), $0.12 worse than the analyst estimate of $0.03.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 22nd Century Group files prospectus for warrant share resale
• Venu Holding enters $250 million at-the-market stock offering agreement